Key Takeaway: Transcatheter Aortic Valve Replacement (TAVR) — also known as TAVI — is a revolutionary, minimally invasive procedure that replaces a narrowed aortic valve without open-heart surgery. In India, top cardiac centers perform this procedure with success rates exceeding 87–91%, at 50% lower costs than the US or UK – with recovery in days, not weeks. This comprehensive guide covers everything from the procedure to success rates, costs, and why India is a preferred global destination for aortic valve replacement.
Table of Contents
1. What Is TAVR? Understanding Transcatheter Aortic Valve Replacement
Imagine replacing a faulty heart valve without opening the chest, without stopping the heart, and without a heart-lung machine. That is the promise of this procedure – a treatment that has transformed the landscape of cardiac care since its first human implantation in 2002.
TAVR (Transcatheter Aortic Valve Replacement), also called TAVI (Transcatheter Aortic Valve Implantation), is a minimally invasive procedure that replaces a diseased aortic valve using a catheter inserted through a blood vessel – typically in the groin. A collapsible replacement valve is delivered to the heart and expanded inside the old, diseased valve, pushing the damaged leaflets aside and restoring normal blood flow.
Unlike traditional open-heart surgery (SAVR), this procedure does not require a sternotomy (cutting through the breastbone), stopping the heart, or using a heart-lung bypass machine. It is performed under local anesthesia or conscious sedation, and most patients are walking within hours.
For patients with severe aortic stenosis who are at high or intermediate risk for surgery, this treatment has become the standard of care. Recent evidence from the PARTNER 3 trial has even extended its benefits to low-risk patients, with equivalent outcomes to surgery at seven years.
External resource: Cleveland Clinic – TAVR Overview
For a broader understanding of aortic valve surgery, read our guide on Heart Valve Replacement Surgery.
2. Who Needs TAVR? Understanding Aortic Stenosis
The aortic valve is the gateway between the heart’s main pumping chamber (left ventricle) and the aorta, the body’s largest artery. When this valve becomes narrowed – a condition called aortic stenosis – the heart must work much harder to pump blood through the smaller opening. Over time, this leads to:
- Chest pain (angina) – due to reduced blood flow to the coronary arteries
- Shortness of breath – especially during physical activity
- Fainting (syncope) – because the brain receives less blood
- Heart failure – as the heart muscle weakens from overwork
- Fatigue and reduced exercise tolerance
Aortic stenosis is most commonly caused by age-related calcification, but it can also result from congenital bicuspid aortic valve (a valve with two leaflets instead of three) or rheumatic fever. It affects approximately 2-3% of people over 65 and up to 10% of those over 80.
This treatment is recommended for patients with severe symptomatic aortic stenosis who are:
- High-risk or inoperable – It was originally developed for patients who could not survive open-heart surgery
- Intermediate-risk – It is now a standard option for this group
- Low-risk – Recent data from the PARTNER 3 trial shows it is equivalent to surgery in low-risk patients at 7 years
Your cardiologist will evaluate your risk using the Society of Thoracic Surgeons (STS) risk score to determine whether this procedure or SAVR is the best option for you.
For patients with other cardiac conditions, explore our guides on Angioplasty and Stenting, PTCA Coronary Angioplasty, and Heart Transplant in India.
3. TAVI vs TAVR – Are They the Same?
Yes. TAVI (Transcatheter Aortic Valve Implantation) and TAVR (Transcatheter Aortic Valve Replacement) are the same procedure. The difference is purely regional:
- TAVR – Preferred term in the United States and North America
- TAVI – Preferred term in Europe and the UK
Both terms describe the same minimally invasive procedure where a catheter delivers a new valve to the heart without opening the chest. Throughout this article, we use TAVR, but the information applies equally to TAVI.
4. The TAVR Procedure – Step by Step
Understanding how this procedure works removes the fear. Here is the exact journey during a typical session, which takes about 1-2 hours:
Step 1: Preparation and Anesthesia
You will receive either general anesthesia (you are asleep) or conscious sedation (you are awake but relaxed). A multidisciplinary team – including interventional cardiologists, cardiac surgeons, imaging specialists, and anesthesiologists – is present throughout.
Step 2: Vascular Access
A small incision is made, usually in the groin (femoral artery) – called the transfemoral approach. This is the most common access route. A thin, flexible tube (catheter) is inserted into the blood vessel.
Step 3: Navigation to the Heart
Using live X-ray imaging (fluoroscopy) and echocardiography, the catheter is carefully threaded through the arteries to the aortic valve.
Step 4: Valve Delivery and Deployment
A collapsible replacement valve (made from biological tissue, typically bovine or porcine) is crimped onto a balloon catheter and delivered to the site of the diseased valve. The balloon is inflated, expanding the new valve inside the old one, pushing the diseased leaflets aside.
Step 5: Completion and Closure
The catheter is removed, and the incision site is closed. You will be moved to a recovery area for monitoring. Most patients are walking within hours and discharged within 1-2 days.
For a visual explanation, Mayo Clinic’s TAVR animation shows how the procedure works.
5. Types of TAVR Approaches – Transfemoral, Transapical & More
Not all patients can have this procedure through the groin. Depending on your anatomy and vascular health, your surgeon may recommend one of these approaches:
- Transfemoral (TF): The most common approach – access through the femoral artery in the groin. This is the least invasive and preferred when possible.
- Transapical (TA): Access through a small incision between the ribs directly into the tip of the heart (apex). Used when groin access is not possible.
- Transaortic (TAo): Access through a small incision in the upper chest directly into the aorta.
- Subclavian/Axillary: Access through the subclavian or axillary artery (under the collarbone).
- Transcaval: Access through the abdominal veins – a newer, less common approach.
Your Heart Team will recommend the best approach based on your vascular anatomy, the condition of your arteries, and other factors.
6. Types of TAVR Valves – Balloon-Expandable vs Self-Expanding
Two main types of valves are used in this procedure:
- Balloon-Expandable Valves: Crimped onto a balloon catheter and expanded by inflating the balloon. Example: Edwards SAPIEN 3. Long-term data shows superior outcomes equivalent to surgery at seven years.
- Self-Expanding Valves: Made of a metal frame that expands on its own when released from the delivery catheter. Example: Medtronic Evolut.
Both valve types are biological (tissue) valves – typically made from bovine (cow) or porcine (pig) pericardium. They do not require lifelong anticoagulation like mechanical valves.
7. TAVR vs SAVR – Minimally Invasive vs Open-Heart Surgery
When choosing between this procedure and SAVR (Surgical Aortic Valve Replacement), here is a side-by-side comparison:
| Factor | TAVR (Minimally Invasive) | SAVR (Open-Heart Surgery) |
|---|---|---|
| Incision | Tiny puncture (groin/chest) | Large chest incision (sternotomy) |
| Heart-Lung Machine | No | Yes – heart is stopped |
| Anesthesia | Local/sedation or general | General anesthesia |
| Procedure Time | 1-2 hours | 3-6 hours |
| Hospital Stay | 1-2 days | 5-10 days |
| Recovery | Weeks | 2-3 months |
| Valve Durability | ~10 years | ~10-15 years (bioprosthetic); 20+ years (mechanical) |
| Rehospitalization | 20.6% at 7 years | 23.5% at 7 years |
Long-Term Outcomes: The PARTNER 3 trial, presented at TCT 2025, showed that at 7 years, this procedure and SAVR had equivalent outcomes in low-risk patients, with no significant differences in death, stroke, or valve durability. Bioprosthetic valve failure was 6.9% vs 7.3% for surgery.
However, a 2025 observational study from the OBSERVANT studies suggested higher 5-year mortality with this procedure compared to SAVR, particularly in patients with reduced ejection fraction. This highlights the importance of individualized decision-making by a multidisciplinary Heart Team.
External resource: Mayo Clinic – TAVR vs SAVR Decision-Making
For a comparison with other cardiac procedures, read our guides on Double, Triple & Quadruple Bypass and LIMA to LAD CABG.
8. TAVR Success Rates – What the Evidence Shows
Success rates have improved dramatically with newer-generation devices and growing operator experience. Here is what the latest evidence shows:
Device and Technical Success
A 2025 study reported a device success rate of 87.5% for this procedure in patients with pure native aortic regurgitation. Another study reported an overall technical success rate of 91.67% and a device success rate of 83.33%.
Short-Term Outcomes
A 2025 study comparing this procedure and SAVR in heart failure patients found that it was associated with favorable early safety outcomes, including lower rates of atrial fibrillation, bleeding, acute kidney injury, and cardiogenic shock.
Long-Term Outcomes – PARTNER 3 (7-Year Data)
The landmark PARTNER 3 trial, presented at TCT 2025, followed low-risk patients for 7 years and found:
- Primary endpoint: 34.6% vs 37.2% with surgery
- Death: 19.5% vs 16.8% (surgery)
- Stroke: 8.5% vs 8.1% (surgery)
- Rehospitalization: 20.6% vs 23.5% (surgery)
- Bioprosthetic valve failure: 6.9% vs 7.3% (surgery) – no difference in durability
At 7 years, the primary endpoint occurred in 22.7% of TAVR patients vs 27.3% of SAVR patients (p=0.01 for non-inferiority). A win ratio analysis showed 28.8% wins, 27.6% wins for surgery, and 43.6% ties.
Five-Year Outcomes
A 2025 study from the prospective OBSERVANT studies found that this procedure had a significantly higher 5-year mortality than SAVR, both in patients with LVEF ≤50% and >50%. However, this was an observational study, and patients were sicker at baseline.
Urgent vs Elective TAVR
A 2025 meta-analysis found that urgent treatment was associated with higher early mortality (HR 1.83, p<0.001), but this difference converged beyond one year (HR 1.01, p=0.83).
External resource: PubMed – TAVR Outcomes Research
9. TAVR Risks and Complications – What You Should Know
While this procedure is generally safe, it carries certain risks. Understanding these honestly helps you make an informed decision:
- Vascular complications: Bleeding or injury at the access site – occurs in 5-10% of cases
- Stroke: Risk is around 2-3% in high-risk patients, lower in low-risk patients
- Pacemaker implantation: Approximately 10-15% of patients may need a permanent pacemaker
- Paravalvular leak (PVL): Mild PVL is common and usually resolves; moderate/severe PVL occurs in 3-5%
- Acute kidney injury (AKI): Risk is lower than with SAVR
- Valve thrombosis: Rare, managed with anticoagulation
- Coronary obstruction: Rare (<1%), but a serious complication
- Annular rupture: Rare but potentially fatal; more common with balloon-expandable valves
Your Heart Team will discuss these risks with you and take every precaution to minimize them. India’s top cardiac centers follow international best practices, with risk profiles comparable to leading Western institutions.
10. Recovery After TAVR – What to Expect
Recovery is significantly faster than traditional open-heart surgery. Here is a detailed timeline of what you can expect:
Immediate Recovery (First 24-48 Hours)
- Most patients are walking within hours of the procedure
- You may feel some grogginess from sedation, but this wears off quickly
- You’ll be monitored in a recovery area for a few hours
- Most patients are discharged within 1-3 days
- You may feel some chest discomfort or pressure, but this is normal and usually resolves quickly
First Week
- Avoid heavy lifting and strenuous activity for the first week
- Keep the access site clean and dry to prevent infection
- Take medications as prescribed – especially antiplatelet therapy
- Most patients return to normal activities within 1-2 weeks
- You may experience some fatigue, but this improves day by day
Long-Term Recovery
- Continue taking medications as prescribed – this is crucial for long‑term success
- Attend follow-up appointments with your cardiologist to monitor your progress
- Adopt a heart‑healthy lifestyle – diet, exercise, and stress management
- Most patients experience complete relief from symptoms and improved quality of life
- Your cardiologist will advise when you can resume more vigorous activities
The success of your treatment depends not just on the procedure itself, but also on your commitment to a healthy lifestyle and adherence to medication. Patients who follow their cardiologist’s advice have excellent long‑term outcomes.
11. Why India for TAVR? Cost, Quality & Expertise
India has emerged as a leading global destination for this procedure, combining world-class cardiac care with exceptional affordability. Here’s why international patients choose India:
- World-Class Interventional Cardiologists: Indian cardiologists are often trained in the US, UK, or Europe and perform hundreds of these procedures annually
- JCI and NABH Accredited Hospitals: The same international quality standards followed by top hospitals in the US and UK
- State-of-the-Art Technology: India’s top hospitals use the latest generation of valves and imaging equipment
- No Waiting Lists: In India, your procedure can be scheduled within days – not months or years
- Exceptional Value: The same procedure, the same technology, at a fraction of the cost
- High-Volume Experience: Indian cardiac centers perform thousands of these procedures annually
A 2026 report from Mumbai noted a 25% year-on-year increase in TAVR procedures, reflecting a broader shift towards minimally invasive therapies that offer shorter hospital stays, faster recovery, and outcomes increasingly comparable to conventional surgery.
India does around 4,000 TAVR procedures annually, but the actual need is estimated to be close to 50,000 – highlighting the vast potential for growth and the availability of expertise.
For UK patients specifically, our guide on Cardiac Surgery in India for UK Patients provides country-specific cost comparisons and travel guidance.
12. TAVR Cost in India – A Detailed Breakdown
One of the biggest advantages of choosing India is the significant cost savings – without compromising on quality or safety. Here is a detailed cost comparison across different countries:
| Country | TAVR Cost (USD) | Hospital Stay | Waiting Time |
|---|---|---|---|
| India | $12,000 – $30,000 | 1-3 days | 3-7 days |
| United States | $75,000 – $125,000+ | 2-5 days | Weeks to months |
| United Kingdom (Private) | $50,000 – $75,000 | 2-5 days | Weeks to months |
| United Kingdom (NHS) | Free at point of use | 2-5 days | 6-18 months |
| Singapore | $40,000 – $60,000 | 2-5 days | 1-3 weeks |
| Thailand | $35,000 – $50,000 | 2-5 days | 1-2 weeks |
What is included in the package in India? Most all‑inclusive packages cover:
- Pre‑operative tests and consultations
- Interventional cardiologist and Heart Team fees
- FDA/CE‑approved valve
- Hospital room (private or semi‑private)
- Post‑operative care and medications
- Follow‑up consultation
- Airport transfers and dedicated case manager
Choosing India can save patients up to 80-85% of treatment costs compared to the US, without compromising on quality or outcomes.
13. Top Hospitals for TAVR in India
MedicHorizon partners with India’s leading cardiac centers, all equipped with advanced technology and experienced Heart Teams who perform these procedures regularly:
Delhi NCR
- Fortis Escorts Heart Institute, New Delhi – A premier cardiac centre with a dedicated structural heart program
- Medanta – The Medicity, Gurugram – One of India’s leading multi-specialty hospitals with a renowned cardiac program
- Indraprastha Apollo Hospital, New Delhi – A JCI-accredited facility with a comprehensive structural heart program
Mumbai
- Kokilaben Dhirubhai Ambani Hospital, Mumbai – One of India’s top multi-specialty hospitals with a highly regarded cardiac program
- Lilavati Hospital, Mumbai – A premier cardiac centre known for its comprehensive cardiac services
Chennai
- Apollo Hospitals, Greams Road, Chennai – A JCI-accredited facility with a comprehensive structural heart program
- Sri Ramachandra Medical Centre, Chennai – A JCI-accredited university hospital with a renowned cardiac centre
Hyderabad
- Care Hospitals, Hyderabad – Has a dedicated structural heart program
- Yashoda Hospitals, Hyderabad – A JCI-accredited facility with a comprehensive cardiac program
Kolkata
- Fortis Hospital, Kolkata – A JCI-accredited facility with a dedicated cardiac centre
- Narayana Hospital, Kolkata – Part of the renowned Narayana Health network, known for high-volume cardiac care
For a complete list of accredited hospitals across India, visit our Hospital Directory.
14. Frequently Asked Questions About TAVR
What is TAVR?
TAVR (Transcatheter Aortic Valve Replacement) is a minimally invasive procedure that replaces a narrowed aortic valve without open-heart surgery. A catheter delivers a collapsible replacement valve to the heart, where it is expanded inside the diseased valve.
Is TAVR the same as TAVI?
Yes. TAVR and TAVI are the same procedure. TAVR is the preferred term in the US, while TAVI is used in Europe and the UK.
Who is a candidate for TAVR?
TAVR is recommended for patients with severe aortic stenosis who are at high, intermediate, or low risk for open-heart surgery. Your cardiologist will evaluate your risk using the STS risk score.
How long does TAVR take?
A TAVR procedure typically takes 1-2 hours, depending on the complexity of the case and the approach used.
How much does TAVR cost in India?
TAVR in India costs between $12,000 and $30,000, which is 80-85% lower than in the US or UK.
What is the success rate of TAVR?
TAVR has high success rates, with device success rates of 87-91% and outcomes comparable to surgery at 7 years. More than 95% of patients experience significant symptom improvement.
What are the risks of TAVR?
Risks include vascular complications, stroke (2-3%), pacemaker implantation (10-15%), paravalvular leak (3-5%), and rare complications like coronary obstruction or annular rupture.
How long is recovery after TAVR?
Most patients are walking within hours and discharged within 1-3 days. Full recovery takes 1-2 weeks, compared to 2-3 months for open-heart surgery.
15. How MedicHorizon Assists with Your TAVR Journey
Choosing this procedure through MedicHorizon ensures seamless coordination and personalized support every step of the way. We provide end-to-end facilitation beyond what a hospital’s international desk can offer:
Pre-Arrival Consultation
We review your medical records and help you select the right hospital and Heart Team. We coordinate remote consultations with the hospital’s cardiac team for a second opinion or pre-operative assessment.
Medical Visa Assistance
We guide you through the e-Medical Visa application process and provide the necessary invitation letters from the hospital.
Travel & Accommodation
We book affordable flights and comfortable accommodation near the hospital – from budget to 5-star options. Complimentary airport pickup and drop-off are included.
Hospital Admission & Daily Coordination
Our coordinator meets you on arrival, assists with hospital admission, and liaises with the medical team on your behalf.
Financial & Insurance Help
We provide transparent cost estimates, explain payment options, and coordinate with your insurer and the hospital’s TPA desk for cashless treatment where possible.
Post-Treatment Follow-Up
We arrange post-discharge consultations and can book a stay at one of our recovery retreats for a relaxing conclusion to your medical journey.
Important: MedicHorizon does not provide medical advice, guarantee outcomes, or assume responsibility for clinical services. All medical decisions are between you and your physicians. Hospital bills are paid directly to the hospital; our charges cover coordination and hospitality services only.
Ready to Explore TAVR in India?
If you or a loved one is considering this procedure, contact MedicHorizon today. We’ll help you understand the process, connect with top cardiologists and hospitals, and plan your journey with transparency, compassion, and care.
📞 Contact us today for a free consultation and personalised quote
📧 Email: contactmedichorizon@gmail.com
🌐 Website: MedicHorizon Hospital Directory
Legal Disclaimer
This article is for general informational and educational purposes only. MedicHorizon is a health hospitality consultancy, not a medical provider, hospital, or licensed medical practitioner. We do not diagnose, treat, prescribe, or offer medical opinions. All information regarding TAVR is based on publicly available data and does not constitute medical advice. You should independently verify all information and consult with qualified healthcare professionals before making any treatment decisions. Any medical procedure carries inherent risks. By using our services, you acknowledge that all medical decisions remain solely your responsibility.